Bronchodilator Efficacy of High-Flow Nasal Cannula in COPD: Vibrating Mesh Nebulizer Versus Jet Nebulizer
Bronchodilatator-Wirksamkeit von High-Flow-Nasenkanüle bei COPD: Vibrating-Mesh-Vernebler versus Jet-Vernebler
Respiratory Care · 2024-02 · 69 (2) · 157-165
DOI: 10.4187/respcare.11139 ↗Auf einen Blick
Bei 17 Personen mit stabiler COPD war Salbutamol über HFNC-VMN dem Jet-Vernebler nicht unterlegen. Beide Verfahren verbesserten FEV1, HFNC-VMN verkürzte zudem die Verneblerzeit.
Fragestellung
Vergleicht Salbutamol über HFNC-VMN mit Jet-Vernebler bei stabiler COPD die Wirkung auf Atemwegs- und Lungenfunktion?
Methode
Randomisierte nicht-Unterlegenheits-Crossover-Studie bei stabiler COPD; Salbutamol über HFNC-VMN oder Jet-Vernebler in zufälliger Reihenfolge, 4-h-Washout.
Ergebnisse
17 Proband:innen. Beide Verfahren verbesserten FEV1 signifikant. Unter HFNC-VMN verbesserten sich zudem mehrere Impulsoszillometrie-Parameter; Verneblerzeit 6 [5–9] min vs. 20 [16–22] min, P < .001.
Schlussfolgerung der Autor:innen
Die Bronchodilatatortherapie über HFNC-VMN war dem Jet-Vernebler bei stabiler COPD nicht unterlegen und verbesserte die Atemwegsmechanik sowie die Verneblerzeit.
Kernaussagen
- Salbutamol über HFNC-VMN war nicht unterlegen
- Beide Verfahren steigerten FEV1 signifikant
- HFNC-VMN verkürzte die Verneblerzeit auf 6 [5–9] min
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Äquivalenzstudie in der Zeitschrift Respiratory Care, online erschienen am 24.01.2024. Verfasst von Itthiphat Arunsurat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Diseases and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailan…. Hauptthemen laut MEDLINE: Bronchodilator Agents, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND: Jet nebulizers are commonly used for bronchodilator therapy in COPD. High-flow nasal cannula with vibrating mesh nebulizer (HFNC-VMN) is a recently developed system; however, few studies have compared the efficacy of bronchodilator administration via HFNC-VMN to jet nebulizer in stable COPD. This study aimed to compare the effect of salbutamol administered via HFNC-VMN versus jet nebulizer on airway and lung function in subjects with stable COPD. METHODS: This randomized non-inferiority crossover physiologic study enrolled subjects with stable COPD. Salbutamol was nebulized via HFNC-VMN or jet nebulizer in random order with a 4-h washout period between crossover sequences. Spirometry, lung volume, and impulse oscillometry were performed at baseline and after each intervention. The primary outcome was change in FEV 1 from baseline. Secondary outcomes included changes in other respiratory-related parameters and nebulization time compared between the 2 devices. RESULTS: Seventeen subjects were enrolled. HFNC-VMN and jet nebulizer both significantly improved FEV 1 from baseline ( P = .005 and P = .002, respectively). The difference between respiratory resistance at 5 Hz and 20 Hz significantly decreased after HFNC-VMN compared to baseline ( P = .02), while no significant change was observed after jet nebulizer ( P = .056). Area of reactance and resonant frequency of reactance were both significantly decreased ( P = .035 and P = .03, respectively), and respiratory reactance at 5 Hz significantly increased ( P = .02) in the HFNC-VMN group compared to baseline indicating improved lung mechanics, with no significant changes with the jet nebulizer. HFNC-VMN had a shorter nebulization time (6 [5–9] min vs 20 [16–22] min, respectively, P < .001). CONCLUSIONS: Bronchodilator therapy via HFNC-VMN was not inferior to jet nebulizer for subjects with stable COPD and can significantly improve airway oscillometry mechanics and decrease nebulization time compared to jet nebulizer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Diseases and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Division of Respiratory Diseases and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. nuttapol.rit@mahidol.ac.th.
- Division of Respirology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada; and Toronto Lung Transplant Programme, Multi-Organ Transplant Unit, University Health Network, Toront…
- Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, O…
Zitieren
APA
Arunsurat, I., Rittayamai, N., Chuaychoo, B., Tangchityongsiva, S., Promsarn, S., Yuenyong, S., Chow, C. W., & Brochard, L. (2024). Bronchodilator Efficacy of High-Flow Nasal Cannula in COPD: Vibrating Mesh Nebulizer Versus Jet Nebulizer. Respiratory Care, 69(2), 157-165. https://doi.org/10.4187/respcare.11139
Vancouver
Arunsurat I, Rittayamai N, Chuaychoo B, Tangchityongsiva S, Promsarn S, Yuenyong S, et al. Bronchodilator Efficacy of High-Flow Nasal Cannula in COPD: Vibrating Mesh Nebulizer Versus Jet Nebulizer. Respiratory Care. 2024;69(2):157-165. doi:10.4187/respcare.11139
BibTeX
@article{Arunsurat2024,
author = {Arunsurat, Itthiphat and Rittayamai, Nuttapol and Chuaychoo, Benjamas and Tangchityongsiva, Suwat and Promsarn, Simaporn and Yuenyong, Somruthai and Chow, Chung-Wai and Brochard, Laurent},
title = {Bronchodilator Efficacy of High-Flow Nasal Cannula in COPD: Vibrating Mesh Nebulizer Versus Jet Nebulizer},
journal = {Respiratory Care},
year = {2024},
volume = {69},
number = {2},
pages = {157--165},
doi = {10.4187/respcare.11139}
}
EUVIMED